Surgical Innovations Reports Stable 2024 Results and Strong Start to 2025

Surgical Innovations ( (GB:SUN) ) just unveiled an update.

Surgical Innovations Group plc reported stable revenues for 2024, with a strong start to 2025, positioning the company for growth. Despite a slight decrease in adjusted EBITDA and a loss in adjusted EPS, the company saw growth in SI-branded products and strong OEM sales. New distribution contracts and product launches, such as LogiTube™, have expanded market presence, particularly in the obesity market. The company is implementing cost-reduction initiatives and has strengthened its UK market position with new distribution agreements, aiming for profitability and market expansion in 2025.

More about Surgical Innovations

Surgical Innovations Group plc specializes in the design, manufacture, and distribution of innovative medical technology for minimally invasive surgery. The company offers products such as port access systems, surgical instruments, and retraction devices, which are sold in the UK and exported globally. The company focuses on providing environmentally responsible solutions with its ‘resposable’ concept, combining reusable and disposable components, and holds exclusive UK distribution rights for specialist products in various surgical fields.

Average Trading Volume: 685,461

Technical Sentiment Signal: Buy

Current Market Cap: £6.53M

For a thorough assessment of SUN stock, go to TipRanks’ Stock Analysis page.